Bleeding and hypercoagulable problems in women.
Konkle
Barbara A
BA
Penn Comprehensive Hemophilia and Thrombosis Program, University of Pennsylvania, PA, USA.
D000022:Abortion, Spontaneous / Q000097:blood / Q000209:etiology; D020016:Activated Protein C Resistance / Q000139:chemically induced; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D004198:Disease Susceptibility; D005165:Factor V / Q000235:genetics; D005260:Female; D006474:Hemorrhagic Disorders / Q000188:drug therapy / Q000453:epidemiology*; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000453:epidemiology / Q000209:etiology; D012727:Sex Characteristics; D019851:Thrombophilia / Q000139:chemically induced / Q000453:epidemiology* / Q000235:genetics / Q000628:therapy; D020246:Venous Thrombosis / Q000209:etiology
D000925:Anticoagulants; D003278:Contraceptives, Oral, Hormonal; C095381:factor V Leiden; D005165:Factor V